What “alvimopan impurities” usually means (and who makes them)
Alvimopan is a drug substance used in the peripherally restricted opioid antagonist class (sold as Entereg in the US). When people search for “alvimopan impurity manufacturers,” they typically mean suppliers that can provide either:
- Specific chemical impurities/related substances of alvimopan for analytical method development and QC (often sold as “impurity standards” or “reference standards”), or
- Custom synthesis of impurity candidates or intermediate compounds linked to the impurity profile.
The key practical point: impurity standards are not always manufactured as standalone, public catalog products. Many are made by specialized reference-standard suppliers or by contract research/manufacturing organizations as custom work.
Which kinds of companies typically supply impurity standards for alvimopan
Search results for this intent generally come from these categories:
- Reference standards and API impurity standard suppliers (sell certified or non-certified impurity standards used in HPLC/LC-MS method qualification).
- Custom chemical synthesis and analytical standards providers (manufacture impurities or related substances under contract).
- Contract development and manufacturing organizations (CDMOs) that can produce small-scale lots of impurities for analytical qualification.
To find actual manufacturers for “alvimopan impurities,” you usually need the exact impurity name/structure (often listed as “Impurity X,” a CAS number, or a precise chemical name) and whether you need a certified reference material (CRM) with documentation (CoA, purity, identity confirmation).
What information you need to identify the right manufacturer
Most manufacturers will ask for one or more of the following so they can quote feasibility and price:
- The exact impurity designation (e.g., “alvimopan impurity A,” “Impurity X,” or “related substance” as used in a specific regulatory filing).
- Chemical name, CAS number, or structural information (SMILES/InChI).
- Target quantity and concentration/purity requirement (mg, g, or larger).
- Intended use: analytical method development, stability studies, release testing, or reference standard.
- Required documentation: CoA only vs. CRM-grade with full characterization.
Can you point to specific “alvimopan impurity” suppliers from the public record?
I can’t name specific alvimopan impurity manufacturers from the information provided in your query alone. “Alvimopan impurity” is also ambiguous because multiple impurities/related substances may be involved, and suppliers vary by which exact impurity they stock or can synthesize.
If you share any of the following, I can help you narrow to likely manufacturer categories and the exact sourcing keywords to use (and how to screen suppliers):
- The impurity identifier(s) (Impurity A/B/X, etc.)
- Any CAS numbers or chemical names you have
- Your target analytical method (e.g., LC-MS vs HPLC-UV)
- Country/region where you want the supplier (US/EU/India/etc.)
What to watch for when sourcing drug-impurity standards
Common pitfalls when buyers source impurity standards include:
- Wrong impurity identity (mis-matched “Impurity X” naming across suppliers or filings).
- Purity not documented at the level you need for qualification.
- Lack of analytical characterization (NMR/LC-MS identity, assigned structure).
- Supply constraints for novel or low-demand impurities (leads to long lead times).
- Regulatory/documentation gaps (CRM vs non-CRM; CoA scope).
Fast way to get to answers: tell me the impurity you need
Reply with the specific alvimopan impurity name/number (or CAS) and what you need it for (method development, QC, stability). Then I can structure a targeted search plan for manufacturers and the exact filters/requirements to request in RFQs.